- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- HCA Houston Healthcare hospital names chief medical officer
- Indiana hospital credits expanded services to employee health insurance switch
- 38 behavioral health executive moves to know
- ChristianaCare’s Graham Cancer Center joins Association of American Cancer Institutes
- ‘The fight is worth it’: How rural hospitals can recover from the brink of closure
- The term ‘payvider’ isn’t very useful
- Hospital ACOs raised Medicare spending 0.8% under ACO REACH: 8 notes
- Payers are pushing the top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- Healthcare ransomware attacks up 14%: 5 things to know
- UHS Texas behavioral hospital names CEO
- Pharmacy leaders are done waiting
- Mentorship vs. sponsorship: What actually gets women into health system C-suites?
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- CMS’ 2027 rules: Why some specialties are ‘on the outside looking in’
- U of Maryland appoints interim dental school dean
- CMS’ ASC rule: Gains for some, cuts for others
- What leaders need to know about rising mental health leave
- Colorado university closes dental clinic abruptly
- Principal to acquire Beam Benefits, dental provider serving 25,000 businesses
- CMS’ next payment move puts spine ASCs in focus
- The functions ASC leaders won’t hand off
- Washington’s noncompete ban: What healthcare employers need to know
- Chattanooga Heart Institute to pay $3.75M to settle data breach lawsuit
- Watson Clinic opens multispecialty ASC
- The era of free anesthesia coverage is over
- ASA, Team Health ink deal
- MaineHealth launches psychiatric nurse practitioner, physician associate fellowship
- California completes statewide behavioral health shift: 3 things to know
- 3 DSOs making headlines
- SALT Dental Partners adds 14-office North Carolina practice
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Aspen Dental targets fast-growing Georgia city for new practice
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- What will make or break the future of DSO success
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
Michigan healthcare freedom community forum
Mobile Phlebotomy of Central Michigan filed a lawsuit in Saginaw County Circuit Court against Covenant HealthCare and phlebotomist Kaleigh Sobanski. The suit states that Sobanski signed a noncompete clause with MPCM, but later went to work for Covenant in violation of the noncompete agreement. MPCM was under contract to Covenant to provide phlebotomists.
Lawsuit alleges Covenant HealthCare poached phlebotomists with non-compete contracts
By Cole Waterman | October 6, 2023SAGINAW, MI — A Saginaw hospital has been targeted by a lawsuit for allegedly poaching phlebotomists. Also named as a defendant is a woman alleged to have violated a non-compete contract that prohibited her from working as a phlebotomist for the institution.
In her attorney’s eyes, the move is punitive, and the five-year noncompete clause is ultimately unenforceable.
Through attorney Errick A. Miles, Mobile Phlebotomy of Central Michigan on Aug. 7 filed its lawsuit in Saginaw County Circuit Court against Covenant HealthCare and phlebotomist Kaleigh Sobanski. The suit states MPCM is a staffing contractor that facilitates phlebotomists getting work in hospitals and health care facilities.
Sobanski was one such worker who signed a noncompete clause with MPCM, the suit states. MPCM was contracted through Covenant to provide them with trained and qualified phlebotomists.
“Contrary to state and federal law, Covenant has been intentionally and deliberately encouraging, aiding and causing MPCM’s contractors to breach their agreements with MPCM and then hiring those individuals as phlebotomy employees,” the suit alleges.
Covenant “surreptitiously poached” Sobanski from MPCM, causing her to breach her contract, the suit alleges.
“My clients were working with Covenant and would provide them staff because they didn’t have any in-house (phlebotomists),” Miles told MLive. “At some point, Covenant determined they wanted to do the service in-house and started poaching my client’s workers.”
As exhibits, Miles included affidavits from two phlebotomists under contract with MPCM. Both stated Covenant staff approached them on several occasions to see if they wanted to work directly for them. The phlebotomists alleged Covenant staff had already told them they hired Sobanski and that her interview was held in Bay City “so that no one from MPCM would find out about it.”
Both wrote Covenant was aware of their non-compete contracts.
“The staff person then advised if Kaleigh could get away with (breaching contract), then anyone could, and the staff person then asked me if I would join them,” one phlebotomist wrote. “I again declined.”
The suit contains the following eight counts:
· Tortious interference with contract against Covenant
· Tortious interference with business relationship and/or expectancy against Covenant
· Breach of contract against Covenant
· Breach of contract against Sobanski
· Tortious interference with contract against Sobanski
· Tortious interference with business relationship and/or expectancy against Sobanski
· Antitrust violations against Covenant
· Conspiracy against both defendants
In the coming weeks, Miles said he plans to file an amended complaint with a second phlebotomist added as a defendant.
Sobanski and the other phlebotomist have retained Bay County attorney Stephan A. Gaus to represent them. In his Aug. 28 response to the suit, Gaus wrote Sobanski, a mother of three who lives in Hope, was terminated by MPCM before being hired by Covenant. While he conceded Sobanski signed a document with MPCM, he wrote it was not a binding contract. He also wrote that Covenant did not “poach” Sobanski.
Speaking with MLive, Gaus said the contract in question prohibits one from working as phlebotomist anywhere in Michigan for five years after termination. This, he maintains, violates a Michigan statute that states non-compete clauses must be “reasonable as to its duration, geographical area, and the type of employment or line of business.”
MPCM terminated Sobanski in June when she declined to sign a new non-compete contract that would serve as a “patch to a loophole,” Gaus said. The new contract would prohibit former MPCM phlebotomists from working for specific Michigan hospitals, Covenant among them, for two years, he added.
Gaus’ other client also refused to sign the new contract, was fired, and then hired by Covenant, he said.
“It has all of the earmarks of a vendetta,” Gaus said of the suit. “I’m advised others did this before and nobody else got sued. It is utterly unenforceable. Now, it’s just whether they can cause this young family a lot of turmoil in going through litigation and paying for litigation.”
Gaus asserted that it will be difficult for MPCM to prove a five-year noncompete clause is a reasonable business interest.
Miles, though, said the contract Sobanski is being sued for violating did not prohibit her from working as a phlebotomist anywhere in the state for five years, but only at specific institutions.
Covenant is represented by Detroit attorney Kimberly J. Ruppel, who declined to comment on the matter when contacted by MLive.
It should be noted that the Federal Trade Commission (FTC) released a Notice of Proposed Rulemaking (NPRM P201200) to prohibit employers from imposing noncompete clauses on workers on January 5, 2023. The Federal Trade Commission is expected to finalize this rule to ban noncompete agreements in employment contracts sometime in April 2024. The FTC estimates that banning noncompete clauses would affect about 30 million American workers.
https://www.ftc.gov/news-events/news/press-releases/2024/04/ftc-announces-rule-banning-noncompetes
Today, the Federal Trade Commission issued a final rule to promote competition by banning noncompetes nationwide, protecting the fundamental freedom of workers to change jobs, increasing innovation, and fostering new business formation.
“Noncompete clauses keep wages low, suppress new ideas, and rob the American economy of dynamism, including from the more than 8,500 new startups that would be created a year once noncompetes are banned,” said FTC Chair Lina M. Khan. “The FTC’s final rule to ban noncompetes will ensure Americans have the freedom to pursue a new job, start a new business, or bring a new idea to market.”
The FTC estimates that the final rule banning noncompetes will lead to new business formation growing by 2.7% per year, resulting in more than 8,500 additional new businesses created each year. The final rule is expected to result in higher earnings for workers, with estimated earnings increasing for the average worker by an additional $524 per year, and it is expected to lower health care costs by up to $194 billion over the next decade. In addition, the final rule is expected to help drive innovation, leading to an estimated average increase of 17,000 to 29,000 more patents each year for the next 10 years under the final rule.
Noncompetes are a widespread and often exploitative practice imposing contractual conditions that prevent workers from taking a new job or starting a new business. Noncompetes often force workers to either stay in a job they want to leave or bear other significant harms and costs, such as being forced to switch to a lower-paying field, being forced to relocate, being forced to leave the workforce altogether, or being forced to defend against expensive litigation. An estimated 30 million workers—nearly one in five Americans—are subject to a noncompete.
Under the FTC’s new rule, existing noncompetes for the vast majority of workers will no longer be enforceable after the rule’s effective date. Existing noncompetes for senior executives - who represent less than 0.75% of workers - can remain in force under the FTC’s final rule, but employers are banned from entering into or attempting to enforce any new noncompetes, even if they involve senior executives. Employers will be required to provide notice to workers other than senior executives who are bound by an existing noncompete that they will not be enforcing any noncompetes against them.
In January 2023, the FTC issued a proposed rule which was subject to a 90-day public comment period. The FTC received more than 26,000 comments on the proposed rule, with over 25,000 comments in support of the FTC’s proposed ban on noncompetes. The comments informed the FTC’s final rulemaking process, with the FTC carefully reviewing each comment and making changes to the proposed rule in response to the public’s feedback.
In the final rule, the Commission has determined that it is an unfair method of competition, and therefore a violation of Section 5 of the FTC Act, for employers to enter into noncompetes with workers and to enforce certain noncompetes.
The Commission found that noncompetes tend to negatively affect competitive conditions in labor markets by inhibiting efficient matching between workers and employers. The Commission also found that noncompetes tend to negatively affect competitive conditions in product and service markets, inhibiting new business formation and innovation. There is also evidence that noncompetes lead to increased market concentration and higher prices for consumers.
Alternatives to Noncompetes
The Commission found that employers have several alternatives to noncompetes that still enable firms to protect their investments without having to enforce a noncompete.
Trade secret laws and non-disclosure agreements (NDAs) both provide employers with well-established means to protect proprietary and other sensitive information. Researchers estimate that over 95% of workers with a noncompete already have an NDA.
The Commission also finds that instead of using noncompetes to lock in workers, employers that wish to retain employees can compete on the merits for the worker’s labor services by improving wages and working conditions.
Changes from the NPRM
Under the final rule, existing noncompetes for senior executives can remain in force. Employers, however, are prohibited from entering into or enforcing new noncompetes with senior executives. The final rule defines senior executives as workers earning more than $151,164 annually and who are in policy-making positions.
Additionally, the Commission has eliminated a provision in the proposed rule that would have required employers to legally modify existing noncompetes by formally rescinding them. That change will help to streamline compliance.
Instead, under the final rule, employers will simply have to provide notice to workers bound to an existing noncompete that the noncompete agreement will not be enforced against them in the future. To aid employers’ compliance with this requirement, the Commission has included model language in the final rule that employers can use to communicate to workers.
The Commission vote to approve the issuance of the final rule was 3-2 with Commissioners Melissa Holyoak and Andrew N. Ferguson voting no. Commissioners’ written statements will follow at a later date.
The final rule will become effective 120 days after publication in the Federal Register.
Once the rule is effective, market participants can report information about a suspected violation of the rule to the Bureau of Competition by emailing noncompete@ftc.gov.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

























